Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: The insulin delivery system rating questionnaire

Diabetes Care

Volumn 28, Issue 1, 2005, Pages 53-58

  Peyrot, Mark ^a,b   Rubin, Richard R ^b  

^a LOYOLA UNIVERSITY MARYLAND   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DAILY LIFE ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SOCIAL INTERACTION; TREATMENT OUTCOME; WELLBEING;

ACTIVITIES OF DAILY LIVING; ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 11844280839     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.1.53     Document Type: Article

References (28)

1. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R: Insulin pump therapy: a meta-analysis. Diabetes Care 26:1079-1087, 2003
2. Pickup J, Keen H: Continuous subcutaneous insulin infusion at 25 years: evidence base for expanding use of insulin pump therapy in type I diabetes. Diabetes Care 25:593-598, 2002
3. Graff MR, McClanahan MA: Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther 20:486-496, 1998
4. Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber JP: Comparisons of continuous subcutaneous insulin infusion and multiple daily insulin injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. Diabetes Care 23:1232-1235, 2000
5. Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RI, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR: Continuous subcutaneous insulin infusion and multiple daily injections are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 26:2598-2603, 2003
6. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ: A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with longstanding poor glycemic control. Diabetes Care 25:2074-2080, 2002
7. Chantelau E, Schiffers T, Schutze J, Hansen B: Effect of patient-selected intensive insulin therapy on quality of life. Patient Educ Counseling 30:167-173, 1997
8. Linkeschova R, Raoul M, Bott U, Berger M, Spraul M: Less severe hypoglycemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSIl) therapy: an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 19:746-751, 2002
9. Shelmet J, Schwartz S, Cappleman J, Paterson G, Skovlund S, Lyness W, Liang J, Lytzen L, Nicklasson L, the Innolet Study Group: Preference and resource utilization in elderly patients: innolet vs. vial/syringe. Diabetes Res Clin Pract 1:27-35, 2004
10. Ristic S, Bates PC, Martin JM, Llewelyn JA: Acceptability of a reusable insulin pen, HumaPen Ergo, by patients with type 1 and type 2 diabetes. Curr Med Res Opin 18:68-71, 2002
11. Sucic M, Galic E, Cabrijan T, Ivandic A, Petrusic A, Wyatt J, Mincheva N, Milicevic A, Malone J: Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled pen in ten Croatian diabetes centres. Med Sci Monit 8:PI21-PI26, 2002
12. Bohannon NJ, Ohannesian JP, Burdan AL, Holcombe JH, Zagar A: Patient and physician satisfaction with the Humilin/Humalog Pen, a new 3.0-Ml prefilled pen device for insulin delivery. Clin Ther 22:1049-1067, 2000
13. Brutomesso D, Pianta A, Crazzolara D, Scaldaferri E, Lora L, Guarneri G, Mongillo A, Gennaro R, Miola M, Moretti M, Confortin L, Beltramello P, Pais M, Baritussion A, Casiglia E, Tiengo A: Continuous subcutaneous insulin infusion (CSU) in the Veneto region: efficacy, acceptability, and quality of life. Diabet Med 19:628-634, 2002
14. Weintrob W, Benzzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M: Comparison of continuous subcutaneous insulin infusion and multiple daily injections in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 112:559-564, 2003
15. Galatzer A, Weintrob N, Cohen D, Benzzaquen H, Rimer A, Ofan R, Mittelman I, Fayman G, Phillip M: Treatment satisfaction of type 1 diabetes patients: continuous subcutaneous insulin infusion versus multiple daily injections (Abstract). Diabetes 51 (Suppl. 2):A619, 2002
16. Helve E, Koivisto VA, Lehtonen A, Pelkonen R, Huttunen J, Nikkila F: A crossover comparison of continuous insulin infusion and conventional injection treatment in type 1 diabetes. Acta Med Scand 221:385-393, 1987
17. Saurbrey N, Arnold-Larsen S, Moeller-Jensen B, Kuhl C: Comparison of continuous subcutaneous insulin infusion with multiple daily injections using the NovoPen. Diabet Med 5:150-153, 1988
18. Bak JF, Nielsen OH, Pedersen O, BeckNeilsen H: Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients. Diabetes Res 6:155-158, 1987
19. Coscelli C, Lostia S, Lunetta M, Noosari I, Coronel GA: Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 28:173-177, 1995
20. Dunbar JM, Madden PM, Gleeson DT, Fiad TM, McKenna TJ: Premixed insulin in pen syringes maintain glycemic control and are preferred by patients. Diabetes Care 17:874-878, 1994
21. Gerber RA, Cappelleri JC, Kourides IA, Gelfand RA: Treatment satisfaction with inhaled insulin in patients with type 1 diabetes. Diabetes Care 24:1556-1559, 2001
22. Jacobson AM: Quality of life in patients with diabetes mellitus. Semin Clin Neuropsychiatry 2:82-93, 1997
23. Snoek FJ: Quality of life: a closer look at measuring patients' well-being. Diabetes Spectrum 13:5-9, 2000
24. The Diabetes Control and Complications Trial Research Group: Influence of intensive diabetes treatment of quality-of-life outcomes in the Diabetes Control and Complications Trial. Diabetes Care 19:195-203, 1996
25. Rubin RR, Peyrot M: Quality of life and diabetes. Diabetes Metab Res Rev 15:205-218, 1999
26. Norman GR, Sloan JA, Wyrwich KW: Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41:582-592, 2003
27. Cohen J: Statistical Power Analysis for the Behavioral Sciences London, Academic Press, 1969
28. Hanestad BR, Albreksten G: Quality of life, perceived difficulties in adherence to diabetes regimen, and blood glucose control. Diabet Med 8:759-764, 1991